Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study

被引：0
|
作者：
Makoto Sakai
Makoto Sohda
Hideyuki Saito
Kengo Kuriyama
Tomonori Yoshida
Yuji Kumakura
Keigo Hara
Takehiko Yokobori
Tatsuya Miyazaki
Kazutoshi Murata
Shin-ei Noda
Takashi Nakano
Hiroyuki Kuwano
Ken Shirabe
机构：
[1] Gunma University,Department of General Surgical Science, Graduate School of Medicine
[2] Gunma University Graduate School of Medicine,Department of Innovative Cancer Immunotherapy
[3] Gunma University Graduate School of Medicine,Department of Radiation Oncology
[4] International Medical Center,Department of Radiation Oncology
[5] Saitama Medical University,undefined
[6] Fukuoka City Hospital,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2019年 / 83卷
关键词：
Cervical esophageal cancer; Chemoradiotherapy; DCF; Prognosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1121 / 1126
页数：5
相关论文
共 50 条
  • [1] Docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy for patients with cervical esophageal cancer: a single-center retrospective study
    Sakai, Makoto
    Sohda, Makoto
    Saito, Hideyuki
    Kuriyama, Kengo
    Yoshida, Tomonori
    Kumakura, Yuji
    Hara, Keigo
    Yokobori, Takehiko
    Miyazaki, Tatsuya
    Murata, Kazutoshi
    Noda, Shin-ei
    Nakano, Takashi
    Kuwano, Hiroyuki
    Shirabe, Ken
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (06) : 1121 - 1126
  • [2] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
    Emi, Manabu
    Hihara, Jun
    Hamai, Yoichi
    Aoki, Yoshiro
    Okada, Morihito
    Kenjo, Masahiro
    Murakami, Yuji
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (06) : 1499 - 1505
  • [3] Neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for esophageal cancer
    Manabu Emi
    Jun Hihara
    Yoichi Hamai
    Yoshiro Aoki
    Morihito Okada
    Masahiro Kenjo
    Yuji Murakami
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 1499 - 1505
  • [4] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
    Tatsuya Miyazaki
    Makoto Sohda
    Naritaka Tanaka
    Shigemasa Suzuki
    Keisuke Ieta
    Makoto Sakai
    Akihiko Sano
    Takehiko Yokobori
    Takanori Inose
    Masanobu Nakajima
    Minoru Fukuchi
    Hitoshi Ojima
    Hiroyuki Kato
    Hiroyuki Kuwano
    Cancer Chemotherapy and Pharmacology, 2015, 75 : 449 - 455
  • [5] Phase I/II study of docetaxel, cisplatin, and 5-fluorouracil combination chemoradiotherapy in patients with advanced esophageal cancer
    Miyazaki, Tatsuya
    Sohda, Makoto
    Tanaka, Naritaka
    Suzuki, Shigemasa
    Ieta, Keisuke
    Sakai, Makoto
    Sano, Akihiko
    Yokobori, Takehiko
    Inose, Takanori
    Nakajima, Masanobu
    Fukuchi, Minoru
    Ojima, Hitoshi
    Kato, Hiroyuki
    Kuwano, Hiroyuki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 75 (03) : 449 - 455
  • [6] Phase II Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Unresectable Esophageal Cancer
    Takahashi, Kosuke
    Osaka, Yoshiaki
    Ota, Yoshihiro
    Watanabe, Takafumi
    Iwasaki, Kenichi
    Tachibana, Shingo
    Nagakawa, Yuichi
    Katsumata, Kenji
    Tsuchida, Akihiko
    ANTICANCER RESEARCH, 2020, 40 (05) : 2827 - 2832
  • [7] Concurrent Chemoradiotherapy with Docetaxel, Cisplatin, and 5-fluorouracil Improves Survival of Patients with Advanced Esophageal Cancer Compared with Conventional Concurrent Chemoradiotherapy with Cisplatin and 5-fluorouracil
    Tamaki, Yukihisa
    Hieda, Yoko
    Nakajima, Masanobu
    Kitajima, Kazuhiro
    Yoshida, Rika
    Yoshizako, Takeshi
    Ue, Atsushi
    Tokudo, Mutsumi
    Hirahara, Noriyuki
    Moriyama, Ichiro
    Kato, Hiroyuki
    Inomata, Taisuke
    JOURNAL OF CANCER, 2018, 9 (16): : 2765 - 2772
  • [8] Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer
    Okamoto, Hiroshi
    Taniyama, Yusuke
    Sakurai, Tadashi
    Heishi, Takahiro
    Teshima, Jin
    Sato, Chiaki
    Maruyama, Shota
    Ito, Ken
    Onodera, Yu
    Konno-Kumagai, Takuro
    Ishida, Hirotaka
    Kamei, Takashi
    ESOPHAGUS, 2018, 15 (04) : 281 - 285
  • [9] Definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) for advanced cervical esophageal cancer
    Hiroshi Okamoto
    Yusuke Taniyama
    Tadashi Sakurai
    Takahiro Heishi
    Jin Teshima
    Chiaki Sato
    Shota Maruyama
    Ken Ito
    Yu Onodera
    Takuro Konno-Kumagai
    Hirotaka Ishida
    Takashi Kamei
    Esophagus, 2018, 15 : 281 - 285
  • [10] Phase I Study of Docetaxel, Cisplatin, and 5-Fluorouracil Chemoradiotherapy for Local or Metastatic Esophageal Cancer
    Iwasaki, Kenichi
    Osaka, Yoshiaki
    Tachibana, Shingo
    Suda, Takeshi
    Ota, Yoshihiro
    Hoshino, Sumito
    Tsuchida, Akihiko
    ANTICANCER RESEARCH, 2016, 36 (03) : 987 - 994
12345